2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
NETWORK
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Breast Neoplasms
77
Neoplasms
69
Prostatic Neoplasms
51
Colorectal Neoplasms
44
Lung Neoplasms
38
Carcinoma, Non-Small-Cell Lung
28
Hematologic Neoplasms
22
Pancreatic Neoplasms
21
Neoplasm Metastasis
20
Head and Neck Neoplasms
19
Urinary Bladder Neoplasms
15
Ovarian Neoplasms
15
Multiple Myeloma
15
Stomach Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
11
Motor Activity
11
Leukemia, Myeloid, Acute
11
Glioblastoma
10
Uterine Cervical Neoplasms
9
Triple Negative Breast Neoplasms
9
Gastrointestinal Neoplasms
9
Colonic Neoplasms
9
Melanoma
8
Hematopoietic and Lymphatic System Neoplasm
8
Glioma
8
Esophageal Neoplasms
8
Carcinoma, Renal Cell
8
COVID-19
8
Anxiety Disorders
8
Anatomic Stage I Breast Cancer AJCC v8
8
Interventions
enzalutamide
7
Prednisone
7
cabazitaxel
6
Radiosurgery
6
Docetaxel
5
Androgen Antagonists
4
Abiraterone Acetate
4
XRP6258
2
Standard of Care
2
talazoparib
1
sipuleucel-T
1
rucaparib
1
pembrolizumab
1
olaparib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
darolutamide
1
apalutamide
1
Zuclomiphene
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Prednisolone
1
Positron Emission Tomography Computed Tomography
1
Pluvicto
1
Midazolam
1
Lutetium-177
1
Lutetium
1
Lenograstim
1
LY3023414
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Prostate Cancer Metastatic
×
Standard of Care
×
Clear all
NCT03784755
2026-03-27
PLATON
Canadian Cancer Trials Group
Phase NA
Active not recruiting
409 enrolled
NCT01360840
2015-12-14
PERSEUS
EMD Serono
Phase 2
Completed
180 enrolled
23 charts